TABLE OF CONTENTS
| | | | Volume 34, Issue 8 (February 2015) | | In this issue Review Original Articles Short Communications
Also new AOP | | | | Review | Top | | Rewiring cell polarity signaling in cancerR Halaoui and L McCaffrey Oncogene 2015 34: 939-950; advance online publication, March 17, 2014; 10.1038/onc.2014.59 Abstract | Full Text | | Original Articles | Top | | Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonizationG Canesin, E P Cuevas, V Santos, C López-Menéndez, G Moreno-Bueno, Y Huang, K Csiszar, F Portillo, H Peinado, D Lyden and A Cano Oncogene 2015 34: 951-964; advance online publication, March 17, 2014; 10.1038/onc.2014.23 Abstract | Full Text | | | | miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinomaX Zhou, C Z Zhang, S-X Lu, G G Chen, L-Z Li, L-L Liu, C Yi, J Fu, W Hu, J-M Wen and J-P Yun Oncogene 2015 34: 965-977; advance online publication, March 17, 2014; 10.1038/onc.2014.35 Abstract | Full Text | | | | Contributions of DNA repair, cell cycle checkpoints and cell death to suppressing the DNA damage-induced tumorigenic behavior of Drosophila epithelial cellsA Dekanty, L Barrio and M Milán Oncogene 2015 34: 978-985; advance online publication, March 17, 2014; 10.1038/onc.2014.42 Abstract | Full Text | | | | The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesisS Hardy, N Uetani, N Wong, E Kostantin, D P Labbé, L R Bégin, A Mes-Masson, D Miranda-Saavedra and M L Tremblay Oncogene 2015 34: 986-995; advance online publication, March 17, 2014; 10.1038/onc.2014.33 Abstract | Full Text | | | | Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motilityV Edmond, F Dufour, G Poiroux, K Shoji, M Malleter, A Fouqué, S Tauzin, R Rimokh, O Sergent, A Penna, A Dupuy, T Levade, N Theret, O Micheau, B Ségui and P Legembre Oncogene 2015 34: 996-1005; advance online publication, March 17, 2014; 10.1038/onc.2014.55 Abstract | Full Text | | | | Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysisQ Wang, B Shen, L Chen, P Zheng, H Feng, Q Hao, X Liu, L Liu, S Xu, J Chen and J Teng Oncogene 2015 34: 1006-1018; advance online publication, March 17, 2014; 10.1038/onc.2014.52 Abstract | Full Text | | | | Prokineticin signaling is required for the maintenance of a de novo population of c-KIT+ cells to sustain neuroblastoma progressionS-T Lau, L M Hansford, W-K Chan, G C-F Chan, T S-K Wan, K K-Y Wong, D R Kaplan, P K-H Tam and E S-W Ngan Oncogene 2015 34: 1019-1034; advance online publication, March 17, 2014; 10.1038/onc.2014.24 Abstract | Full Text | | | | Unique roles of estrogen-dependent Pten control in epithelial cell homeostasis of mouse vaginaS Miyagawa, M Sato, T Sudo, G Yamada and T Iguchi Oncogene 2015 34: 1035-1043; advance online publication, March 17, 2014; 10.1038/onc.2014.62 Abstract | Full Text | | Short Communications | Top | | PCK2 activation mediates an adaptive response to glucose depletion in lung cancerK Leithner, A Hrzenjak, M Trötzmüller, T Moustafa, H C Köfeler, C Wohlkoenig, E Stacher, J Lindenmann, A L Harris, A Olschewski and H Olschewski Oncogene 2015 34: 1044-1050; advance online publication, March 17, 2014; 10.1038/onc.2014.47 Abstract | Full Text | | | | Heterogeneity in ERK activity as visualized by in vivo FRET imaging of mammary tumor cells developed in MMTV-Neu miceY Kumagai, H Naoki, E Nakasyo, Y Kamioka, E Kiyokawa and M Matsuda Oncogene 2015 34: 1051-1057; advance online publication, March 17, 2014; 10.1038/onc.2014.28 Abstract | Full Text | | | | USP29 controls the stability of checkpoint adaptor Claspin by deubiquitinationY Martín, E Cabrera, H Amoedo, S Hernández-Pérez, R Domínguez-Kelly and R Freire Oncogene 2015 34: 1058-1063; advance online publication, March 17, 2014; 10.1038/onc.2014.38 Abstract | Full Text | | | | DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplificationC V Camacho, P K Todorova, M C Hardebeck, N Tomimatsu, C R Gil del Alcazar, M Ilcheva, B Mukherjee, B McEllin, V Vemireddy, K Hatanpaa, M D Story, A A Habib, V V Murty, R Bachoo and S Burma Oncogene 2015 34: 1064-1072; advance online publication, March 17, 2014; 10.1038/onc.2014.29 Abstract | Full Text | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | | |
No comments:
Post a Comment